Status:
UNKNOWN
Effects of Melatonin on Reperfusion Injury
Lead Sponsor:
Chinese PLA General Hospital
Conditions:
Reperfusion Injury, Myocardial
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
Acute myocardial infarction is a major cause of mortality and morbidity. Primary percutaneous coronary intervention (pPCI) is currently the most effective treatment strategy in acute myocardial infarc...
Eligibility Criteria
Inclusion
- ST segment elevation myocardial infarction undergoing primary percutaneous poronary intervention
Exclusion
- unconscious at presentation
- had cardiogenic shock
- had a history of myocardial infarction
- stent thrombosis
- renal insufficiency
- had previously undergone coronary artery bypass surgery
Key Trial Info
Start Date :
November 1 2017
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2019
Estimated Enrollment :
190 Patients enrolled
Trial Details
Trial ID
NCT03303378
Start Date
November 1 2017
End Date
November 1 2019
Last Update
October 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
PLA General Hospital
Beijing, Beijing Municipality, China, 100853